BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7978176)

  • 1. [The optimal administration time for neostigmine following atracurium blockade. Kinetics of antagonists].
    Nielsen HK; May O
    Anaesthesist; 1994 Aug; 43(8):528-33. PubMed ID: 7978176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of intense neuromuscular blockade following infusion of atracurium.
    Engbaek J; Ostergaard D; Skovgaard LT; Viby-Mogensen J
    Anesthesiology; 1990 May; 72(5):803-6. PubMed ID: 2160206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
    Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting atracurium reversal time.
    Kirkegaard-Nielsen H; Severinsen IK; Pedersen HS; Lindholm P
    Acta Anaesthesiol Scand; 1999 Sep; 43(8):834-41. PubMed ID: 10492412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of atracurium-induced block in obese patients.
    Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
    Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
    Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
    Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of epidurally administered bupivacaine on atracurium-induced neuromuscular blockade.
    Toft P; Kirkegaard Nielsen H; Severinsen I; Helbo-Hansen HS
    Acta Anaesthesiol Scand; 1990 Nov; 34(8):649-52. PubMed ID: 2275325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of post-tetanic count and train-of-four response during intense neuromuscular blockade caused by atracurium.
    Bonsu AK; Viby-Mogensen J; Fernando PU; Muchhal K; Tamilarasan A; Lambourne A
    Br J Anaesth; 1987 Sep; 59(9):1089-92. PubMed ID: 2822066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated reversal of atracurium blockade with divided doses of neostigmine.
    Abdulatif M; Naguib M
    Can Anaesth Soc J; 1986 Nov; 33(6):723-8. PubMed ID: 3779494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium.
    Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ
    Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does repetition of post-tetanic count every 3 min during profound relaxation affect accelerographic recovery of atracurium blockade?
    Motamed C; Kirov K; Combes X; Duvaldestin P
    Acta Anaesthesiol Scand; 2005 Jul; 49(6):811-4. PubMed ID: 15954964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Priming reversal of profound atracurium blockade by edrophonium and neostigmine.
    Liu CH; Lin IS; Liu CG; Peng TH; Yeh YJ; Chuu LJ; Lin SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 May; 11(5):257-64. PubMed ID: 7602663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reversal from non-depolarising neuromuscular blockade in the postoperative period].
    Gaszyński T; Szlachciński L; Jakubiak J; Gaszyński W
    Anestezjol Intens Ter; 2009; 41(1):11-5. PubMed ID: 19517671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double burst monitoring during recovery from atracurium-induced neuromuscular blockade: a comparison with train-of-four.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Severinsen IK; Lindholm P; Bülow K
    Int J Clin Monit Comput; 1996 Nov; 13(4):209-15. PubMed ID: 9080241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade.
    Trévien V; Lienhart A; Just B; Chandon M; Baras E; Camatte S
    Acta Anaesthesiol Scand Suppl; 1995; 106():66-9. PubMed ID: 8533550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.